ChartRow logo
ARGX
argenx SE American Depositary SharesStock · Health Care
$875.30+$7.36 (+0.85%)as of market close, Aug 6, 2026
CompareLLYUNHJNJABBVISRGTMO

ARGXargenx SE American Depositary Shares stock price, chart and key statistics

Key stats

Price data

Price
$875.30
Change YTD
+4.08%
Market cap
54.2B
Enterprise value
50.7B
Shares outstanding
61.9M
52W low
$631.47
52W high
$953.58
From 52W high
-8.21%
From 52W low
+38.61%
52W range
76%
Beta
0.45

Volume

Rel volume
0.74×
30D volume
307.6K
30D $ vol
273.2M

Fundamentals

EPS (ttm)
$19.57
FCF (ttm)
685.2M
FCF/share
$11.07
Book value/share
$118.34
ROE
17.64%
ROA
14.88%
Current ratio
5.23

Growth (CAGR, ttm) · 10Y

Sales
n/a
Net income
n/a
Shares
n/a

Per-share growth (CAGR, ttm) · 10Y

EPS
n/a
Sales/share
n/a
Book value/share
n/a
Price
n/a
Total return
n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
44.7×
Fwd P/E
21.6×
P/B (mrq)
7.4×
P/FCF (ttm)
79.1×
EV/EBITDA (fy)
48.1×
FCF yield (ttm)
1.26%
Buyback yield (realized, 1y)
-1.85%
Shareholder yield (realized, 1y)
-1.85%
Buyback yield (cash, ttm)
0.00%
Shareholder yield (cash, ttm)
0.00%

Vs own 10Y history

P/S
86th
P/B
48th

Bar = where today's multiple sits in ARGX's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance · price return

1D
+0.85%
1W
+0.31%
1M
-4.37%
3M
+8.39%
YTD
+4.08%
1Y
+29.69%
5Y
+195.86%

Financial statements

Open full ARGX financials →

Related Health Care

1M
TickerThemePrice1M30D $Vol
NVS
Novartis AG
$154-0.62%295.9M
AZN
AstraZeneca PLC
$161-14.90%597.2M
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
$52.17-0.67%223.6M
NVO
Novo Nordisk A/S
$45.97-5.97%575.6M
SNY
Sanofi ADS
$42.89+0.26%152.5M
RVMD
Revolution Medicines Inc.
$198+4.24%463.3M
TEVA
Teva Pharmaceutical Industries Limited American Depositary Shares
$34.81+4.72%179.6M
NTRA
Natera Inc.
$265-3.28%360.8M

argenx SE American Depositary Shares (ARGX) trades at $875.30 with a live price and an interactive chart covering 9+ years of daily price history, plus key valuation metrics. ChartRow also publishes ARGX's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full ARGX financial statements →